Microglia in Gliomas: Friend or Foe?

Bozena Kaminska

DOI: https://doi.org/10.1007/978-3-7091-1431-5_9

2014-01-01

Abstract:Microglia are myeloid cells residing in the central nervous system that regulate innate and adaptive immune responses in development, infections, and neuropathological disorders. Clinical and experimental data show that microglia constitute the dominant immune infiltrate in malignant gliomas. The clinical significance of the mononuclear infiltrate in gliomas remains the subject of controversy. Despite accumulation of these immune cells in both low and high grade gliomas, the antitumor immune response is defective in glioblastomas. Some evidence shows the immunosuppressive and pro-invasive action of glioblastoma-infiltrating microglia. Molecular mechanisms responsible for dual and likely opposite role of these cells are being recently unraveled. This chapter summarizes the latest findings on the heterogeneity of glioma-infiltrating microglia/macrophages, functional characterization of their phenotype, and contribution to glioma pathology. Recent attempts to determine a profile of cytokine/chemokine production and gene expression profiling in CD11b+ cells isolated from patients or rodent gliomas revealed their similarity to alternatively activated, the M2-type macrophages observed in other tissues. Glioma-infiltrating microglia/macrophages acquire the alternative, pro-invasive phenotype in which their phagocytic, trophic, and tissue remodeling functions are enhanced. Cell culture and organotypic brain slice culture studies demonstrated the pro-invasive activity of microglia, and their polarization into tumor supportive cells. This is supported by studies of rodent experimental gliomas which reproduce glioblastoma pathology. Genetic or pharmacological ablation of microglia/macrophages impairs glioma growth, extends survival, and in some cases restores to some extent antitumor immune responses. The potential for targeting interactions between glioma and infiltrating microglia/macrophages in therapeutic interventions is discussed. Small molecule inhibitors of mitogen-activated protein kinase (MAPK)-signaling with immunosuppressive or anti-inflammatory properties, such as cyclosporine A and minocycline, were shown to block infiltration and activation of microglia in vitro and in organotypic brain slices. These molecules reduce infiltration of microglia/macrophages, angiogenesis, and tumor growth of experimental gliomas providing a rationale for blocking pro-invasive functions of microglia/macrophages as a new therapeutic strategy in glioblastomas.